Healthcare partnerships Strong traction with healthcare networks evidenced by Kaiser Permanente deployment in Sterile Processing and the Scarborough Health Network collaboration, presenting a clear path for expanding into large hospital systems and affiliated facilities.

Facility adoption Adoption by high-safety/clean environments like hospitals and five-star hotels indicates broad demand for chemical-free UV-C sanitization solutions to protect devices and patient/facility safety, suggesting upsell opportunities to facility managers and procurement.

Product launches Recent Versa launch and ongoing emphasis on rigorously tested, intuitive devices point to opportunities around new product bundles, pilots, and trials with facilities seeking scalable, easy-to-deploy sanitization tech.

Funding signals Historical funding activity, including a 7M round in 2020 and overall 9.2M funding, supports credibility for customer pilots and potential co-investment discussions or grant-aligned procurement in healthcare and safety programs.

UV-C visibility Strategic partnerships with UV-C dosimeter providers to visualize effectiveness can be leveraged to sell to vendors and hospital programs that require measurable, auditable hygiene outcomes and compliance reporting.